Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma

Radiotherapy and Oncology

Volumn 104, Issue 3, 2012, Pages 312-316

  Su, Sheng Fa ^a   Huang, Ying ^b   Xiao, Wei Wei ^b   Huang, Shao Ming ^b   Han, Fei ^b   Xie, Chuan Miao ^b   Lu, Tai Xiang ^b  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Temporal lobe injury

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; CANCER ADJUVANT THERAPY; CANCER STAGING; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; TEMPORAL LOBE; TEMPORAL LOBE LESION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIATION DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TEMPORAL LOBE;

EID: 84867068575     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.06.012     Document Type: Article

References (15)

1. A.W. Lee, D.L. Kwong, and S.F. Leung Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time Int J Radiat Oncol Biol Phys 53 2002 75 85
2. Y. Tang, Y. Li, and F. Zhang Clinical characteristics and changes in living quality of patients with radiation encephalopathy induced by radiation therapy for treating nasopharyngeal carcinoma Neural Regen Res 2 2007 99 102
3. M.C. Cheung, A.S. Chan, S.C. Law, J.H. Chan, and V.K. Tse Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma Cancer 97 2003 2019 2026
4. A.W. Lee, S.C. Law, and S.H. Ng Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation Br J Radiol 65 1992 918 928
5. A.W. Lee, W. Foo, and R. Chappell Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 40 1998 35 42
6. C. Mayo, E. Yorke, and T.E. Merchant Radiation associated brainstem injury Int J Radiat Oncol Biol Phys 76 2010 S36 S41
7. Y.R. Lawrence, X.A. Li, and I. el Naqa Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 2010 S20 S27
8. S.F. Su, F. Han, and C. Zhao Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone Int J Radiat Oncol Biol Phys 82 2012 327 333
9. W.W. Xiao, S.M. Huang, and F. Han Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study Cancer 117 2011 1874 1883
10. C. Lin, and W.Q. Zheng Radiation encephalopathy induced by radiotherapy in nasopharyngeal carcinoma: a clinical study of 16 cases Chin J Neuromed 9 2010 736 739
11. Y. Tian, Z.R. Gou, and M.F. Zhu Radiation encephalopathy in nasopharyngeal carcinoma patients in mainland China: a systematic evaluation Chin J Oncol 24 2002 471 473
12. R.L. Bakst, N. Lee, and D.G. Pfister Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial Int J Radiat Oncol Biol Phys 80 2011 148 153
13. N. Lee, J. Harris, and A.S. Garden Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 27 2009 3684 3690
14. Y.J. Liu, J.L. Yi, and H. OuYang MRI findings of radiation-induced encephalopathy in nasopharyngeal carcinoma Chin J Radiat Oncol 9 2000 225 228
15. R.M. Chau, P.M. Teo, and M.K. Kam Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord Med Dosim 32 2007 263 270